EP3688010A4 - Dosage sérologique pour la détection d'une exposition à des agents pathogènes portés par les tiques et d'une infection par ceux-ci - Google Patents

Dosage sérologique pour la détection d'une exposition à des agents pathogènes portés par les tiques et d'une infection par ceux-ci Download PDF

Info

Publication number: EP3688010A4
Authority: EP; European Patent Office
Prior art keywords: tick; infection; serological test; detect exposure; agents
Prior art date: 2017-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP18857606.0A

Other languages

German (de)

English (en)

Other versions

EP3688010A1 (fr

Inventor

Rafal TOKARZ

Walter Ian Lipkin

Nischay MISHRA

Thomas Briese

Adrian CACIULA

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Columbia University in the City of New York

Original Assignee

Columbia University in the City of New York

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-09-25

Filing date

2018-09-25

Publication date

2021-08-18

2018-09-25 Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York

2020-08-05 Publication of EP3688010A1 publication Critical patent/EP3688010A1/fr

2021-08-18 Publication of EP3688010A4 publication Critical patent/EP3688010A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43552—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects
- G01N2333/43556—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects from ticks

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Pathology (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Virology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Bioinformatics & Computational Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)

EP18857606.0A 2017-09-25 2018-09-25 Dosage sérologique pour la détection d'une exposition à des agents pathogènes portés par les tiques et d'une infection par ceux-ci Withdrawn EP3688010A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201762562634P	2017-09-25	2017-09-25
PCT/US2018/052625 WO2019060885A1 (fr)	2017-09-25	2018-09-25	Dosage sérologique pour la détection d'une exposition à des agents pathogènes portés par les tiques et d'une infection par ceux-ci

Publications (2)

Publication Number	Publication Date
EP3688010A1 EP3688010A1 (fr)	2020-08-05
EP3688010A4 true EP3688010A4 (fr)	2021-08-18

Family

ID=65810615

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18857606.0A Withdrawn EP3688010A4 (fr)	2017-09-25	2018-09-25	Dosage sérologique pour la détection d'une exposition à des agents pathogènes portés par les tiques et d'une infection par ceux-ci

Country Status (2)

Country	Link
EP (1)	EP3688010A4 (fr)
WO (1)	WO2019060885A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20210215715A1 (en) *	2020-01-10	2021-07-15	Quidel Corporation	Test strip with structured substrate for multiplex lateral flow assay for disease diagnostics
US20240319178A1 (en) *	2020-12-30	2024-09-26	Quest Diagnostics Investments Llc	Compounds, kits, and methods for bead-based detection of anti-microbe antibodies
WO2025054519A2 (fr) *	2023-09-08	2025-03-13	Vibrant Holdings, Llc	Procédés, systèmes et réseaux pour l'analyse d'agents pathogènes transmis par les tiques et de maladies transmises par les tiques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013116668A2 (fr) *	2012-02-01	2013-08-08	Biopeptides Corp	Peptides diagnostiques pour la maladie de lyme

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4366246A (en)	1977-11-08	1982-12-28	Genentech, Inc.	Method for microbial polypeptide expression
US5618533A (en) *	1992-02-11	1997-04-08	Yale University	Flagellin-based polypeptides for the diagnosis of lyme disease
US8758772B2 (en) *	2011-11-04	2014-06-24	Abaxis, Inc.	Peptides and methods for the detection of lyme disease antibodies
DK3489685T3 (da)	2011-11-21	2023-12-04	Zoetis Services Llc	Signalforstærkning i sidestrømning og tilsvarende immunoassays
WO2015070037A2 (fr) *	2013-11-08	2015-05-14	Prognosys Biosciences, Inc.	Conjugués de polynucléotides et procédés de détection d'analytes

2018
- 2018-09-25 EP EP18857606.0A patent/EP3688010A4/fr not_active Withdrawn
- 2018-09-25 WO PCT/US2018/052625 patent/WO2019060885A1/fr not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013116668A2 (fr) *	2012-02-01	2013-08-08	Biopeptides Corp	Peptides diagnostiques pour la maladie de lyme

Also Published As

Publication number	Publication date
EP3688010A1 (fr)	2020-08-05
WO2019060885A1 (fr)	2019-03-28

Publication	Publication Date	Title
EP3721408A4 (fr)	2021-09-01	Inspection de réticules au moyen d'un apprentissage automatique
MA46525A (fr)	2019-08-21	Anticorps anti-lag-3 et compositions
EP3974823C0 (fr)	2024-03-06	Robot d'inspection
EP3638557A4 (fr)	2021-02-24	Détection d'une défaillance et réponse à la défaillance
EP3725802A4 (fr)	2021-08-11	Anticorps anti-synucléine et leurs utilisations
EP3759503C0 (fr)	2025-07-16	Dispositif d'essai
EP3743525A4 (fr)	2021-09-29	Procédés et compositions de détection de proximité
EP3604494A4 (fr)	2020-11-18	Dispositif d'inspection
EP3511698A4 (fr)	2020-04-01	Dispositif de mesure non destructive
PL3899476T3 (pl)	2022-12-12	Sposób wykrywania i zapobiegania wyciekom
EP2954301C0 (fr)	2024-06-12	Compositions de coloration cytologique et leurs utilisations
EP4043859C0 (fr)	2024-09-25	Dispositif de test et/ou d'essai
EP3633093A4 (fr)	2020-12-30	Appareil de traitement de linge
EP3258948C0 (fr)	2023-12-06	Compositions anti-inflammatoires et immunomodulatoires comprenant klebsormidium et utilisations de celles-ci
EP3141902C0 (fr)	2023-08-09	Dispositif de test d'urine
EP3968039A4 (fr)	2023-01-25	Dispositif de test de charge
EP3845909A4 (fr)	2022-05-18	Dispositif de dosage
EP3688010A4 (fr)	2021-08-18	Dosage sérologique pour la détection d'une exposition à des agents pathogènes portés par les tiques et d'une infection par ceux-ci
EP3669196C0 (fr)	2025-01-01	Dispositif de test
EP4007480A4 (fr)	2022-08-03	Dispositif d'inspection
EP3550270A4 (fr)	2020-08-05	Dispositif de mesure
EP3694403A4 (fr)	2020-12-09	Dispositifs de mesure de coaptation de valve
EP3497447C0 (fr)	2024-09-04	Compositions, dispositifs, et procédés d'évaluation de la sensibilité à la depression
EP3557249A4 (fr)	2020-09-30	Dispositif de test d'urine et procédé de test d'urine
EP3850142C0 (fr)	2023-08-30	Appareil de traitement de vêtements

Legal Events

Date	Code	Title	Description
2019-03-30	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2020-07-03	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-07-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-08-05	17P	Request for examination filed	Effective date: 20200414
2020-08-05	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-08-05	AX	Request for extension of the european patent	Extension state: BA ME
2020-12-30	DAV	Request for validation of the european patent (deleted)
2020-12-30	DAX	Request for extension of the european patent (deleted)
2021-05-19	RIC1	Information provided on ipc code assigned before grant	Ipc: C07K 7/08 20060101AFI20210412BHEP Ipc: C07K 14/20 20060101ALI20210412BHEP Ipc: C07K 14/435 20060101ALI20210412BHEP Ipc: C07K 16/12 20060101ALI20210412BHEP Ipc: G01N 33/50 20060101ALI20210412BHEP Ipc: G01N 33/53 20060101ALI20210412BHEP Ipc: G01N 33/536 20060101ALI20210412BHEP Ipc: G01N 33/554 20060101ALI20210412BHEP Ipc: G01N 33/569 20060101ALI20210412BHEP Ipc: C07K 14/005 20060101ALI20210412BHEP Ipc: C07K 14/29 20060101ALI20210412BHEP Ipc: C07K 14/44 20060101ALI20210412BHEP Ipc: G01N 33/68 20060101ALI20210412BHEP
2021-08-18	A4	Supplementary search report drawn up and despatched	Effective date: 20210721
2021-08-18	RIC1	Information provided on ipc code assigned before grant	Ipc: C07K 7/08 20060101AFI20210715BHEP Ipc: C07K 14/20 20060101ALI20210715BHEP Ipc: C07K 14/435 20060101ALI20210715BHEP Ipc: C07K 16/12 20060101ALI20210715BHEP Ipc: G01N 33/50 20060101ALI20210715BHEP Ipc: G01N 33/53 20060101ALI20210715BHEP Ipc: G01N 33/536 20060101ALI20210715BHEP Ipc: G01N 33/554 20060101ALI20210715BHEP Ipc: G01N 33/569 20060101ALI20210715BHEP Ipc: C07K 14/005 20060101ALI20210715BHEP Ipc: C07K 14/29 20060101ALI20210715BHEP Ipc: C07K 14/44 20060101ALI20210715BHEP Ipc: G01N 33/68 20060101ALI20210715BHEP
2023-06-14	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230314
2025-07-11	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2025-08-13	18D	Application deemed to be withdrawn	Effective date: 20250401